HARBIN, China, May 4, 2011 /PRNewswire-Asia-FirstCall/ — China
Sky One Medical, Inc. (“China Sky One Medical” or “the Company”)
CSKI), a leading fully integrated pharmaceutical company in the
People’s Republic of China (“PRC”), today announced that it will
conduct a conference call at 9:00 a.m. Eastern Time (ET) on
Thursday, May 12, 2011, to discuss first quarter 2011 financial
results. A full version of the Company’s quarterly report will be
filed with the SEC on Form 10-Q prior to the call.
To participate in the live conference call, please dial the
following number five to ten minutes prior to the scheduled
conference call time: 866-395-5819. International callers should
dial 706-643-6986. The Conference ID for this call is 63344218.
If you are unable to participate in the call at this time, a
replay will be available for two weeks starting on Thursday, May
12, 2011 at 12:00 a.m. ET. To access the replay, dial 800-642-1687,
international callers dial 706-645-9291. The Conference Replay
Passcode is 63344218.
About China Sky One Medical, Inc. China Sky One Medical,
Inc., a Nevada corporation, is a holding company. The Company
engages in the manufacturing, marketing and distribution of
pharmaceutical, medicinal and diagnostic products. Through its
wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and
Technology Company (“TDR”), Harbin First Bio-Engineering Company
Limited (“First”), Heilongjiang Tianlong Pharmaceutical, Inc.
(“Tianlong”) and Peng Lai Jin Chuang Pharmaceutical Company (“Jin
Chuang”) the Company manufactures and distributes over-the-counter
pharmaceutical products, which make up its major revenue source.
For more information, visit http://www.cski.com.cn.Company
Contact:Investor Relations Contact:China Sky One Medical, Inc.CCG
Investor RelationsHongyu Pan, CFO
Mr. Crocker Coulso